Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Japan's Eisai Co Ltd said on Thursday it would price its cancer drug Lenvima at about $16,000 for a month's supply before discounts, after the U.S. Food and Drug Administration approved its use in patients with a common form of liver cancer.
from Reuters: Health News https://reut.rs/2PgUurs
http://bit.ly/2zwRqiM